Tenon Medical, Inc. (TNON)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

2Y 5Y 10Y All
Quarterly Annual TTM

Revenue TTM

0 2M 4M 6M Q4 '21: 160K Q1 '22: 216K Q2 '22: 329K Q3 '22: 467K Q4 '22: 691K Q1 '23: 1.1M Q2 '23: 1.7M Q3 '23: 2.4M Q4 '23: 2.9M Q1 '24: 3.2M Q2 '24: 3.4M Q3 '24: 3.3M Q4 '24: 3.3M Q1 '25: 3.3M Q2 '25: 2.9M Q3 '25: 3.2M Q4 '25: 3.9M Q1 '26: 4.6M Q2 '26: 5.3M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Gross Profit TTM

-1.5M 0 1.5M 3M 4.5M Q4 '21: 105K Q1 '22: -103K Q2 '22: -252K Q3 '22: -398K Q4 '22: -641K Q1 '23: -484K Q2 '23: -154K Q3 '23: 475K Q4 '23: 1.2M Q1 '24: 1.8M Q2 '24: 2M Q3 '24: 1.9M Q4 '24: 1.7M Q1 '25: 1.6M Q2 '25: 1.3M Q3 '25: 1.7M Q4 '25: 2.4M Q1 '26: 3M Q2 '26: 3.5M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Income TTM

-24M -16M -8M 0 8M 16M 24M Q4 '21: -6.5M Q1 '22: -8.4M Q2 '22: -12.2M Q3 '22: -13.4M Q4 '22: -18.7M Q1 '23: -21.5M Q2 '23: -20.4M Q3 '23: -20.5M Q4 '23: -15.7M Q1 '24: -14.3M Q2 '24: -13.9M Q3 '24: -13.7M Q4 '24: -13.8M Q1 '25: -13.9M Q2 '25: -12.9M Q3 '25: -13.1M Q4 '25: -12.8M Q1 '26: -12.4M Q2 '26: -12.9M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Net Income TTM

-24M -16M -8M 0 8M 16M 24M Q4 '21: -7M Q1 '22: -9.2M Q2 '22: -13M Q3 '22: -13.9M Q4 '22: -18.9M Q1 '23: -21.4M Q2 '23: -20.2M Q3 '23: -20.4M Q4 '23: -15.6M Q1 '24: -14.3M Q2 '24: -13.9M Q3 '24: -13.7M Q4 '24: -13.7M Q1 '25: -13.7M Q2 '25: -12.7M Q3 '25: -12.8M Q4 '25: -12.6M Q1 '26: -12.4M Q2 '26: -13.7M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue TTM

0 700K 1.4M 2.1M Q4 '21: 55K Q1 '22: 319K Q2 '22: 581K Q3 '22: 865K Q4 '22: 1.3M Q1 '23: 1.5M Q2 '23: 1.8M Q3 '23: 1.9M Q4 '23: 1.7M Q1 '24: 1.5M Q2 '24: 1.3M Q3 '24: 1.4M Q4 '24: 1.6M Q1 '25: 1.7M Q2 '25: 1.6M Q3 '25: 1.5M Q4 '25: 1.6M Q1 '26: 1.6M Q2 '26: 1.8M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Cash Flow TTM

-15M -10M -5M 0 5M 10M 15M Q4 '21: -4.3M Q1 '22: -6.6M Q2 '22: -8.3M Q3 '22: -10.3M Q4 '22: -12M Q1 '23: -13.1M Q2 '23: -13.6M Q3 '23: -13.3M Q4 '23: -12.2M Q1 '24: -10.9M Q2 '24: -10.2M Q3 '24: -9.4M Q4 '24: -9.9M Q1 '25: -10M Q2 '25: -9.8M Q3 '25: -11.3M Q4 '25: -10.7M Q1 '26: -11.2M Q2 '26: -11.8M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow TTM

-15M -10M -5M 0 5M 10M 15M Q4 '21: -4.4M Q1 '22: -6.8M Q2 '22: -8.6M Q3 '22: -10.7M Q4 '22: -12.9M Q1 '23: -13.9M Q2 '23: -14.4M Q3 '23: -14.2M Q4 '23: -12.5M Q1 '24: -11.3M Q2 '24: -10.5M Q3 '24: -9.7M Q4 '24: -10.1M Q2 '26: -12.1M Q1 '22 Q3 '22 Q1 '23 Q3 '23 Q1 '24 Q3 '24 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 4K 8K 12K Q2 '21: 830 Q3 '21: 919 Q1 '22: 990 Q2 '22: 8.4K Q3 '22: 1.1K Q1 '23: 1.1K Q2 '23: 1.3K Q3 '23: 285 Q1 '24: 357 Q2 '24: 469 Q3 '24: 877 Q1 '25: 3.6K Q2 '25: 217 Q3 '25: 8.2K Q1 '26: 11.3K Q2 '26: 328 Q3 '21 Q2 '22 Q1 '23 Q3 '23 Q2 '24 Q1 '25 Q3 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.